SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-215668
Filing Date
2020-08-11
Accepted
2020-08-11 07:58:04
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d235715ds3.htm S-3 434321
2 EX-1.2 d235715dex12.htm EX-1.2 164531
3 EX-4.4 d235715dex44.htm EX-4.4 362399
4 EX-4.5 d235715dex45.htm EX-4.5 344130
5 EX-4.6 d235715dex46.htm EX-4.6 43700
6 EX-4.7 d235715dex47.htm EX-4.7 42967
7 EX-5.1 d235715dex51.htm EX-5.1 33663
8 EX-23.1 d235715dex231.htm EX-23.1 1595
9 GRAPHIC g235715g0810213555181.jpg GRAPHIC 2011
10 GRAPHIC g235715g0810213555540.jpg GRAPHIC 7169
11 GRAPHIC g235715g16p88.jpg GRAPHIC 44179
  Complete submission text file 0001193125-20-215668.txt   1498301
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-244136 | Film No.: 201091080
SIC: 2834 Pharmaceutical Preparations